Indeed, restoration of ARRDC3 synthesis in breast cancer cells improved ligand-induced degradation of PAR1, inhibited its persistent activation and thus attenuated PAR1-dependent cancer cell invasiveness [139]. Here, ARRDC3 is linked to breast cancer.